Header cover image

Swiss Pharmaceuticals & Biotech Pure Equity Growth

Results

1

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

1 companies

Kuros Biosciences

Market Cap: CHF 831.8m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

KURN

CHF 20.90

7D

6.6%

1Y

-29.8%